BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 10321259)

  • 1. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
    Kerstens MN; Dullaart RP
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
    Tomlinson JW; Stewart PM
    Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
    Stewart PM; Murry BA; Mason JI
    J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11 beta-Hydroxysteroid dehydrogenase.
    Stewart PM; Krozowski ZS
    Vitam Horm; 1999; 57():249-324. PubMed ID: 10232052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [11 beta-Hydroxysteroid dehydrogenase].
    Sun G; Li P; Yang KP; Challis JR
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):301-6. PubMed ID: 12501657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension.
    Donovan SJ
    Br J Biomed Sci; 1999; 56(3):215-25. PubMed ID: 10824333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
    Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC
    Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM; Whorwood CB; Walker BR
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Agarwal AK
    Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.
    van Uum SH; Lenders JW; Hermus AR
    Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
    Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
    Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R; Edwards CR
    Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.
    Stewart PM; Murry BA; Mason JI
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1529-32. PubMed ID: 8200959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.